3,4-methylenedioxyamphetamine has been researched along with Sensitivity and Specificity in 28 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Excerpt | Relevance | Reference |
---|---|---|
" A total of 31 healthy Chinese subjects participated in the pharmacokinetic study of single bolus intravenous injection of piperphentonamine hydrochloride." | 2.77 | Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers. ( Han, L; Hu, X; Li, J; Li, K; Li, R; Shi, A; Wan, H, 2012) |
" The statistical distribution of the drug concentrations compared with the self-reported consumption behaviour of the users may possibly lead to a better understanding of the relationship between drug dosage and corresponding concentrations in hair." | 1.29 | Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers. ( Kauert, G; Röhrich, J, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (28.57) | 18.2507 |
2000's | 18 (64.29) | 29.6817 |
2010's | 2 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sun, J | 1 |
Xu, X | 1 |
Wang, C | 1 |
You, T | 1 |
Sergi, M | 1 |
Bafile, E | 1 |
Compagnone, D | 1 |
Curini, R | 1 |
D'Ascenzo, G | 1 |
Romolo, FS | 1 |
da Silva, DG | 1 |
de Pinho, PG | 1 |
Pontes, H | 1 |
Ferreira, L | 1 |
Branco, P | 1 |
Remião, F | 1 |
Carvalho, F | 1 |
Bastos, ML | 1 |
Carmo, H | 1 |
Shi, A | 1 |
Hu, X | 1 |
Li, K | 1 |
Li, J | 1 |
Han, L | 1 |
Wan, H | 1 |
Li, R | 1 |
Carter, JF | 1 |
Titterton, aE | 1 |
Murray, M | 1 |
Sleeman, R | 1 |
Murray, RA | 1 |
Doering, PL | 1 |
Boothby, LA | 1 |
Merves, ML | 1 |
McCusker, RR | 1 |
Chronister, CW | 1 |
Goldberger, BA | 1 |
Tsai, CH | 1 |
Fang, C | 1 |
Liu, JT | 1 |
Lin, CH | 1 |
Marchioro, L | 1 |
Bassetto, F | 1 |
Dall'Olio, G | 1 |
Tedeschi, L | 1 |
Castagna, F | 1 |
Plebani, M | 1 |
da Costa, JL | 1 |
da Matta Chasin, AA | 1 |
Laloup, M | 1 |
Tilman, G | 1 |
Maes, V | 1 |
De Boeck, G | 2 |
Wallemacq, P | 1 |
Ramaekers, J | 1 |
Samyn, N | 2 |
Peters, FT | 1 |
Lamers, CT | 1 |
Riedel, WJ | 1 |
Kraemer, T | 1 |
Maurer, HH | 1 |
Pirnay, SO | 1 |
Abraham, TT | 1 |
Huestis, MA | 1 |
Tomita, M | 1 |
Nakashima, MN | 1 |
Wada, M | 1 |
Nakashima, K | 1 |
Shima, N | 1 |
Kamata, H | 1 |
Katagi, M | 1 |
Tsuchihashi, H | 2 |
Sakuma, T | 1 |
Nemoto, N | 1 |
Poklis, A | 1 |
Fitzgerald, RL | 1 |
Hall, KV | 1 |
Saady, JJ | 1 |
Kauert, G | 1 |
Röhrich, J | 1 |
Pisternick, W | 1 |
Kovar, KA | 2 |
Ensslin, H | 1 |
Sadeghipour, F | 1 |
Veuthey, JL | 1 |
Keller, T | 1 |
Miki, A | 1 |
Regenscheit, P | 1 |
Dirnhofer, R | 1 |
Schneider, A | 1 |
Uotila, J | 1 |
Solakivi, T | 1 |
Jaakkola, O | 1 |
Tuimala, R | 1 |
Lehtimäki, T | 1 |
Hensley, D | 1 |
Cody, JT | 1 |
Ugland, HG | 1 |
Krogh, M | 1 |
Rasmussen, KE | 1 |
Borth, S | 1 |
Hänsel, W | 1 |
Rösner, P | 1 |
Junge, T | 1 |
Clauwaert, KM | 1 |
Van Bocxlaer, JF | 1 |
De Letter, EA | 1 |
Van Calenbergh, S | 1 |
Lambert, WE | 1 |
De Leenheer, AP | 1 |
Backofen, U | 1 |
Matysik, FM | 1 |
Hoffmann, W | 1 |
Lunte, CE | 1 |
Brunnenberg, M | 1 |
Pizarro, N | 1 |
Ortuño, J | 1 |
Farré, M | 1 |
Hernández-López, C | 1 |
Pujadas, M | 1 |
Llebaria, A | 1 |
Joglar, J | 1 |
Roset, PN | 1 |
Mas, M | 1 |
Segura, J | 1 |
Camí, J | 1 |
de la Torre, R | 1 |
Birnbaum, GE | 1 |
Reis, HT | 1 |
4 trials available for 3,4-methylenedioxyamphetamine and Sensitivity and Specificity
Article | Year |
---|---|
Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cardiovascular Agents; Chromatography, High Pressu | 2012 |
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Dose-Response Relationship, Drug | 2005 |
Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Autoantibodies; Copper; Female; Gestational Age; Humans; Lipop | 1998 |
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Deoxyepinephrine; Electrophoresis, Capillary; Gas Chromatography-Mass | 2002 |
24 other studies available for 3,4-methylenedioxyamphetamine and Sensitivity and Specificity
Article | Year |
---|---|
Analysis of amphetamines in urine with liquid-liquid extraction by capillary electrophoresis with simultaneous electrochemical and electrochemiluminescence detection.
Topics: 2,2'-Dipyridyl; 3,4-Methylenedioxyamphetamine; Amphetamines; Electrochemical Techniques; Electrophor | 2008 |
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure | 2009 |
Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Metham | 2010 |
Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
Topics: 3,4-Methylenedioxyamphetamine; Drug and Narcotic Control; Gas Chromatography-Mass Spectrometry; Illi | 2002 |
Putting an Ecstasy test kit to the test: harm reduction or harm induction?
Topics: 3,4-Methylenedioxyamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic; Rep | 2003 |
Stacking and low-temperature technique in nonaqueous capillary electrophoresis for the analysis of 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Electrophoresis, Capillary; Sensitivity and Specificity; Spectrophoto | 2004 |
Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamines; Chromatography, High Pressure Liquid | 2004 |
Determination of MDMA, MDEA and MDA in urine by high performance liquid chromatography with fluorescence detection.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Forensic Medicine; Humans; N-Me | 2004 |
Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometr | 2005 |
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Calibration; Central Nervous System Stimulants; Dopamin | 2006 |
Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Benzoates; Blood Chemical Analysis; Brain Chemistry; Calibra | 2007 |
Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Calibration; Designer Drugs; Gas Chrom | 2007 |
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Cross Reactions; Designer Drugs; Gas Chromatogr | 1993 |
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dron | 1996 |
High-performance thin-layer chromatographic determination of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in urine and comparison with high-performance liquid chromatography.
Topics: 3,4-Methylenedioxyamphetamine; Calibration; Chromatography, High Pressure Liquid; Chromatography, Th | 1997 |
Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; N-Methyl- | 1997 |
Detection of designer drugs in human hair by ion mobility spectrometry (IMS).
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Medicine; Hair; Hallucinogens; Humans; N-Met | 1998 |
Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Gas Chromatography-M | 1999 |
Automated determination of 'Ecstasy' and amphetamines in urine by SPME and capillary gas chromatography after propylchloroformate derivatisation.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Esters; Evaluation Studies as Topic; Fo | 1999 |
Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Central Nervous System Stimulants; Designer Drugs; Gas Chromatography | 2000 |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, High Pressure Liquid; Designer Drugs; Humans | 2000 |
Analysis of illicit drugs by nonaqueous capillary electrophoresis and electrochemical detection.
Topics: 3,4-Methylenedioxyamphetamine; Acetonitriles; Amphetamines; Cocaine; Electrophoresis, Capillary; Hal | 2000 |
Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamphetamine and its metabolites in humans.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Humans; N-Methyl-3,4-methylened | 2001 |
Women's sexual working models: an evolutionary-attachment perspective.
Topics: Adult; Aged; Female; Humans; Interpersonal Relations; Love; Middle Aged; Models, Psychological; Pers | 2006 |